EDITAS MEDICINE INC. - COMMON STOCK

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

14 أغسطس 2024 10:49:50 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

12 أغسطس 2024 09:46:03 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

09 أغسطس 2024 10:12:14 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

07 أغسطس 2024 11:59:49 بحسب NetDania Notify

Editas Medicine Announces Second Quarter 2024 Results and Business Updates

07 أغسطس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

05 أغسطس 2024 09:45:15 بحسب NetDania Notify

Editas Medicine Announces Second Quarter 2024 Results Conference Call and Corporate Update

31 يوليو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

02 يوليو 2024 09:45:34 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

01 يوليو 2024 14:01:29 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

28 يونيو 2024 09:47:12 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

27 يونيو 2024 09:45:34 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

26 يونيو 2024 10:52:15 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

17 يونيو 2024 10:19:53 بحسب NetDania Notify

Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual Congress

14 يونيو 2024 03:01:00 بحسب Nasdaq GlobeNewswire

Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual Congress

14 يونيو 2024 03:00:00 بحسب Nasdaq GlobeNewswire

Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June

14 مايو 2024 10:00:00 بحسب Nasdaq GlobeNewswire

Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting

10 مايو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

08 مايو 2024 09:49:21 بحسب NetDania Notify

Editas Medicine Announces First Quarter 2024 Results and Business Updates

08 مايو 2024 07:00:01 بحسب Nasdaq GlobeNewswire

Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events

02 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire